Spero Biopharma

About

Q&A

What is Spero Biopharma's primary focus?

Spero Biopharma focuses on the prevention and treatment of Alzheimer's Disease, specifically developing Ladostigil to treat mild cognitive impairment.

Where is Spero Biopharma headquartered?

Spero Biopharma is headquartered in Ramat HaSharon, Center District, Israel.

When was Spero Biopharma founded?

Spero Biopharma was founded in June 2019.

What is the current employee count for Spero Biopharma?

Spero Biopharma has 1-10 employees.

What is the current product stage of Spero Biopharma's main drug?

Spero Biopharma's main drug, Ladostigil, is currently in the clinical trial stage.

In which sector does Spero Biopharma primarily operate?

Spero Biopharma operates primarily in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.

Does Spero Biopharma hold any patents?

Yes, Spero Biopharma holds 1 patent.

What is Spero Biopharma's current funding stage?

Spero Biopharma is currently in the Pre-Funding stage.

Team · 2

Moti Hacham

Founder · CEO

LinkedIn ↗

Marta Weinstock-Rosin

Founder · Founder

Sectors & technology

Highlights

Tags